
News from Stemwell Science News
Top Stemwell Science News News

Medical · WorcesterPatients in a Phase I/II clinical trial conducted by UMass Chan Medical School of a dual vector gene therapy for GM2 gangliosidosis, which includes Tay-Sachs and Sandhoff diseases, exhibited a biochemical correction of the disease with minimal adverse reactions.See the Story
Dual Vector Gene Therapy Trial Offers Hope for Tay-Sachs and Sandhoff Diseases
100% Center coverage: 1 sources

United States · United StatesThe federal government has for decades invested vigorously in research aimed at narrowing the health gaps between racial and socioeconomic groups, pouring billions of dollars into understanding why minority and low-income Americans have shorter lives and suffer higher rates of…See the Story
With Deep NIH Cuts, Research Into Health Disparities Falters
100% Center coverage: 1 sources

United States · United StatesHalda Therapeutics announced that the US FDA granted Fast Track designation to HLD-0915, the company’s lead development candidate, for the treatment of patients with mCRPC. [Halda Therapeutics] Press ReleaseSee the Story